Treatments for Atopic Eczema
... This has meant that the HTA panels can now focus more explicitly on health technologies (‘health technologies’ are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care) rather than settings of care. Therefore th ...
... This has meant that the HTA panels can now focus more explicitly on health technologies (‘health technologies’ are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care) rather than settings of care. Therefore th ...
Ropinirole 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg and 5 mg
... Ropinirole 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg Film-Coated Tablets are used to treat the symptoms of moderate to severe idiopathic Restless Legs Syndrome. Moderate to severe Restless Legs Syndrome is typically represented by patients who have difficulty sleeping or severe discomfort in their ...
... Ropinirole 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg Film-Coated Tablets are used to treat the symptoms of moderate to severe idiopathic Restless Legs Syndrome. Moderate to severe Restless Legs Syndrome is typically represented by patients who have difficulty sleeping or severe discomfort in their ...
Committee papers
... its 'second-line ICER' because of: Generalisability issues (see clinical effectiveness key issues). Evidence of a non-statistically-significant treatment effect in older groups. The inflexibility of the model to truly reflect an older population. The fact that, other than parametric models, ...
... its 'second-line ICER' because of: Generalisability issues (see clinical effectiveness key issues). Evidence of a non-statistically-significant treatment effect in older groups. The inflexibility of the model to truly reflect an older population. The fact that, other than parametric models, ...
Attachment 2: Extract from the Clinical Evaluation Report for
... The TGA administers the Therapeutic Goods Act 1989 (the Act), applying a risk management approach designed to ensure therapeutic goods supplied in Australia meet acceptable standards of quality, safety and efficacy (performance), when necessary. ...
... The TGA administers the Therapeutic Goods Act 1989 (the Act), applying a risk management approach designed to ensure therapeutic goods supplied in Australia meet acceptable standards of quality, safety and efficacy (performance), when necessary. ...
XIFAXAN (rifaximin) Tablets, 550 mg NDA 21-361
... In the US, rifaximin 200 mg tablets (XIFAXAN®) were approved in 2004 for the treatment of TD caused by noninvasive strains of Escherichia coli (E. coli) (200 mg three times daily [TID] for 3 days). In 2010, rifaximin 550 mg tablets (XIFAXAN®) were approved for the reduction in risk of overt HE recur ...
... In the US, rifaximin 200 mg tablets (XIFAXAN®) were approved in 2004 for the treatment of TD caused by noninvasive strains of Escherichia coli (E. coli) (200 mg three times daily [TID] for 3 days). In 2010, rifaximin 550 mg tablets (XIFAXAN®) were approved for the reduction in risk of overt HE recur ...
A Randomised Control Trial - e-publications@RCSI
... infections with CoNS. Resistance to mupirocin and chlorhexidine limits the options for patients who may benefit from MRSA suppression or decolonisation therapy. Alternative agents such as octenidine dihydrochloride, polyhexanide, ethanol (70%), sodium hypochlorite, lysostaphin, omiganon pentahydroch ...
... infections with CoNS. Resistance to mupirocin and chlorhexidine limits the options for patients who may benefit from MRSA suppression or decolonisation therapy. Alternative agents such as octenidine dihydrochloride, polyhexanide, ethanol (70%), sodium hypochlorite, lysostaphin, omiganon pentahydroch ...
Pe diatri c M igra ine Donald W. Lewis,
... lives of millions of individuals. The origins of the disability can be traced into childhood and adolescence for most adult migraine sufferers.1 Accurate diagnosis and aggressive treatment interventions during childhood and adolescence are essential to prevent the decades of suffering and diminished ...
... lives of millions of individuals. The origins of the disability can be traced into childhood and adolescence for most adult migraine sufferers.1 Accurate diagnosis and aggressive treatment interventions during childhood and adolescence are essential to prevent the decades of suffering and diminished ...
Ezetimibe and rosuvastatin - Therapeutic Goods Administration (TGA)
... The TGA administers the Therapeutic Goods Act 1989 (the Act), applying a risk management approach designed to ensure therapeutic goods supplied in Australia meet acceptable standards of quality, safety and efficacy (performance), when necessary. ...
... The TGA administers the Therapeutic Goods Act 1989 (the Act), applying a risk management approach designed to ensure therapeutic goods supplied in Australia meet acceptable standards of quality, safety and efficacy (performance), when necessary. ...
Anti-vascular endothelial growth factor (VEGF) drugs for
... The information in this report is intended to help Canadian health care decision-makers, health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the quality of health care services. The information in this report should not be used as a s ...
... The information in this report is intended to help Canadian health care decision-makers, health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the quality of health care services. The information in this report should not be used as a s ...
Extended-Release Tablets, USP (SR)
... It is important that patients continue to receive counseling and support throughout treatment with bupropion hydrochloride extended-release tablets (SR) and for a period of time thereafter. 2.3 Individualization of Therapy Patients are more likely to quit smoking and remain abstinent if they are see ...
... It is important that patients continue to receive counseling and support throughout treatment with bupropion hydrochloride extended-release tablets (SR) and for a period of time thereafter. 2.3 Individualization of Therapy Patients are more likely to quit smoking and remain abstinent if they are see ...
Postoperative Analgesia and Vomiting
... he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS. Research is undert ...
... he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS. Research is undert ...
Azelastine Hydrochloride 0.1% Nasal Spray Azelastine
... Long-Term (12 Month) Safety Trial: In the 12 month, open-label, active-controlled, long-term safety trial, 862 patients 12 years of age and older with perennial allergic and/or nonallergic rhinitis were treated with Azelastine Hydrochloride Nasal Spray 0.1% two sprays per nostril twice daily or Aste ...
... Long-Term (12 Month) Safety Trial: In the 12 month, open-label, active-controlled, long-term safety trial, 862 patients 12 years of age and older with perennial allergic and/or nonallergic rhinitis were treated with Azelastine Hydrochloride Nasal Spray 0.1% two sprays per nostril twice daily or Aste ...
report released today
... not a key part of our Evidence Check. Historically, some medical interventions were demonstrably effective before anyone understood their modes of action. For example, after 150 years of use, there is still debate about precisely how anaesthetics work.22 It is more important to know whether a treatm ...
... not a key part of our Evidence Check. Historically, some medical interventions were demonstrably effective before anyone understood their modes of action. For example, after 150 years of use, there is still debate about precisely how anaesthetics work.22 It is more important to know whether a treatm ...
Abstracts of the 23rd Cochrane Colloquium
... data of markers that had also been assessed, but for which no accuracy results were reported (unpublished data). Authors of another 14 articles were contacted because they could have data from which accuracy estimates could be calculated. Seven shared the requested data, and we also included one con ...
... data of markers that had also been assessed, but for which no accuracy results were reported (unpublished data). Authors of another 14 articles were contacted because they could have data from which accuracy estimates could be calculated. Seven shared the requested data, and we also included one con ...
Clinical Study Report
... To be completed by all patients who took at least one dose of trial medication including those who discontinue early. Vital status information has to be collected on the originally planned follow up visit date (Visit 7). Haematology and blood chemistry (local laboratory). White bloodcell count, eosi ...
... To be completed by all patients who took at least one dose of trial medication including those who discontinue early. Vital status information has to be collected on the originally planned follow up visit date (Visit 7). Haematology and blood chemistry (local laboratory). White bloodcell count, eosi ...
DRUGDEX DRUG EVALUATIONS
... digitoxin and cholestyramine can result in a reduction of digitoxin halflife from 11.5 days to 6.6 days, presumably by interruption of the enterohepatic circulation of digitoxin. Digitoxin toxicity has been treated with cholestyramine with some success (Bazzano & Bazzano, 1972a). c. Carruthers & Duj ...
... digitoxin and cholestyramine can result in a reduction of digitoxin halflife from 11.5 days to 6.6 days, presumably by interruption of the enterohepatic circulation of digitoxin. Digitoxin toxicity has been treated with cholestyramine with some success (Bazzano & Bazzano, 1972a). c. Carruthers & Duj ...
Extract from Clinical Evaluation Report: Ivermectin
... Scabies is currently endemic in remote northern and central Aboriginal communities where up to 50% of children may be infested. By the age of one, up to 60% of indigenous children will have been affected by scabies. Rates of crusted scabies (the most severe form of the disease) in these communities ...
... Scabies is currently endemic in remote northern and central Aboriginal communities where up to 50% of children may be infested. By the age of one, up to 60% of indigenous children will have been affected by scabies. Rates of crusted scabies (the most severe form of the disease) in these communities ...
T Clear choices in managing epidermal tinea infections Applied Evidence
... are generally considered fungicidal. Terbinafine has recently been made available over-thecounter as 1% cream and 1% solution, while naftifine remains a prescription medication. Both agents are efficacious, with cure rates for dermatomycosis greater than 75%.17,18 Naftifine and terbinafine have exhi ...
... are generally considered fungicidal. Terbinafine has recently been made available over-thecounter as 1% cream and 1% solution, while naftifine remains a prescription medication. Both agents are efficacious, with cure rates for dermatomycosis greater than 75%.17,18 Naftifine and terbinafine have exhi ...
ION - Boston Scientific
... Table 14.5.1 Typical ION Stent System compliance...............................................18 15 WARRANTY.............................................................................................................................18 ...
... Table 14.5.1 Typical ION Stent System compliance...............................................18 15 WARRANTY.............................................................................................................................18 ...
Evidence-based Clinical Statement
... The evidence-based clinical statement provides a set of recommendations for clinical practice based on this evidence. Physiotherapists can use this evidence to facilitate their role in the management of ankle sprains. Ankle injuries are prevalent in weight bearing sports and activities (Garrick 1977 ...
... The evidence-based clinical statement provides a set of recommendations for clinical practice based on this evidence. Physiotherapists can use this evidence to facilitate their role in the management of ankle sprains. Ankle injuries are prevalent in weight bearing sports and activities (Garrick 1977 ...
TAXUS® Liberté™
... • Stent thrombosis is a low frequency event that current drug-eluting stent (DES) clinical trials are not adequately powered to fully characterize. Stent thrombosis is frequently associated with myocardial infarction (MI) or death. Data from TAXUS Stent randomized clinical trials have been evaluate ...
... • Stent thrombosis is a low frequency event that current drug-eluting stent (DES) clinical trials are not adequately powered to fully characterize. Stent thrombosis is frequently associated with myocardial infarction (MI) or death. Data from TAXUS Stent randomized clinical trials have been evaluate ...
Research in Your Backyard
... the safety and effectiveness of that treatment in patients. Some trials are also conducted to compare existing treatments and some are done to learn if a drug is appropriate for a different patient population, such as children. Still others are conducted to find ways to make existing approved drugs ...
... the safety and effectiveness of that treatment in patients. Some trials are also conducted to compare existing treatments and some are done to learn if a drug is appropriate for a different patient population, such as children. Still others are conducted to find ways to make existing approved drugs ...
These highlights do not include all the information needed
... There have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. Corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. Studies in pregnant rats with intravaginal dos ...
... There have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. Corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. Studies in pregnant rats with intravaginal dos ...
ZITHROMAX®
... regimen of 500 mg on Day 1 and 250 mg/day on Days 2-5, Cmin and Cmax remained essentially unchanged from Day 2 through Day 5 of therapy. However, without a loading dose, azithromycin Cmin levels required 5 to 7 days to ...
... regimen of 500 mg on Day 1 and 250 mg/day on Days 2-5, Cmin and Cmax remained essentially unchanged from Day 2 through Day 5 of therapy. However, without a loading dose, azithromycin Cmin levels required 5 to 7 days to ...
ZITHROMAX (azithromycin tablets) and
... of “Resistant” indicates that usually achievable drug concentrations are unlikely to be inhibitory and that other therapy should be selected. Measurement of MIC or MBC and achieved antimicrobial compound concentrations may be appropriate to guide therapy in some infections. (See CLINICAL PHARMACOLOG ...
... of “Resistant” indicates that usually achievable drug concentrations are unlikely to be inhibitory and that other therapy should be selected. Measurement of MIC or MBC and achieved antimicrobial compound concentrations may be appropriate to guide therapy in some infections. (See CLINICAL PHARMACOLOG ...